Cargando...
Therapeutic Targets for Multiple Sclerosis: Current Treatment Goals and Future Directions
Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system, and the most common cause of nontraumatic disability in young adults. Most patients have a relapsing–remitting course, and roughly half of them will eventually enter a degenerative progressive phase, marked...
Guardado en:
| Publicado en: | Neurotherapeutics |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5722758/ https://ncbi.nlm.nih.gov/pubmed/28653282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-017-0548-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|